Skip to main content
Clinical Trials/NCT02395003
NCT02395003
Completed
Not Applicable

Study to Investigate Adipocyte Cell and Lipid Turnover in Obese Adolescents

Yale University1 site in 1 country26 target enrollmentApril 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Pediatric Obesity
Sponsor
Yale University
Enrollment
26
Locations
1
Primary Endpoint
Fat Biopsies
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Insulin Resistance is the best predictor of whether the obese adolescent will develop type 2 diabetes. The present studies will focus on determining what might cause fat to accumulate in the subcutaneous fat regions and lead to local inflammation, causing insulin resistance to develop in obese adolescents.

Detailed Description

The purpose of this study is to test whether the reduced transcription of key lipogenic/adipogenic genes in abdominal subcutaneous adipose tissue (SAT) in obese adolescents with a High VAT/SAT (visceral adipose tissue/subcutaneous adipose tissue) ratio translates functionally into a reduced in vivo triglyceride (TG) synthesis and adipocyte proliferation, which in turn will contribute to ectopic fat accumulation and insulin resistance (IR). To test whether the storage capacity of gluteal SAT is linked to the level of VAT/SAT fat distribution in obese adolescents. To explore if changes in dietary fat intake (palmitate intake) alters ceramide concentration in both plasma and adipose tissue (AT) and the Inflammasome complex in the different fat distribution phenotypes and their associations with IR.

Registry
clinicaltrials.gov
Start Date
April 2016
End Date
March 7, 2023
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Overweight (85-95th% age and gender specific) or Obese (\>95th% age and gender specific)
  • Ages 12-18 years
  • Absence of any endocrinopathy
  • Absence of any therapy with medication known to alter glucose metabolism (i.e.: Oral steroids, certain psychiatric medications such as Xeleca, Lithium, Paxil)
  • English Speaking subjects

Exclusion Criteria

  • Any disease known to alter glucose metabolism (T2DM)
  • Diuretic Medication
  • Pregnant or breastfeeding
  • Type 1 or 2 diabetes

Outcomes

Primary Outcomes

Fat Biopsies

Time Frame: Baseline

1) To test whether the reduced transcription of key lipogenic/adipogenic genes in abd SAT in obese adolescents with a High VAT/SAT ratio translates functionally into a reduced in vivo TG synthesis and adipocyte proliferation, which in turn will contribute to ectopic fat accumulation and IR.

Secondary Outcomes

  • MRI(Baseline)

Study Sites (1)

Loading locations...

Similar Trials